Medigene AG to participate at BIO International in Boston
Planegg/Martinsried, May 30, 2023. Medigene AG (Medigene, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, will participate at the BIO International Convention, taking place June 5-8, 2023 in Boston, MA.
BIO International Convention
Date: June 5-8, 2023,
Medigene’s management team will be available for one-on-one meetings at the event. Please contact Sandya von der Weid of LifeSci Advisors at [email protected] to schedule a meeting.
--- end of press release ---
About Mediene AG
About Medigene’s End-To-End Platform
In case you no longer wish to receive any information about Medigene, please inform us by e-mail ([email protected]). We will then delete your address from our distribution list.
SESSION DETAILS PENDING
The Connection Between Technology, Employee Experience, and Business Success